Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burk

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Plos One|January 31, 2015
Delayed contrast enhancement imaging of a murine model for ischemia reperfusion with carbon nanotube micro-CTLaurel M Burk, Ko-Han Wang, John Matthew Wait, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 27, 2016
Eosinophilic esophagitis during peanut oral immunotherapy with omalizumabCaitlin M Burk, Evan S Dellon, Pamela H Steele, et al.
The American Journal of Gastroenterology|January 13, 2016
Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic PhenotypeThomas M Runge, Swathi Eluri, Cary C Cotton, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2015
Modified peanut oral immunotherapy protocol safely and effectively induces desensitizationJ Andrew Bird, Matthew Feldman, Amy Arneson, et al.
Annals of Hematology|June 1, 1994
Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemiaA Heyll, C Aul, F Gogolin, et al.
Advances in Experimental Medicine and Biology|April 1, 2003
Ocular hypotensive activity of prostaglandin F2 alpha (PGF2 alpha) analogs with neutral substituents at position 1 is predicted by the isolated cat iris sphincter smooth muscle preparation but not Ca+ signalling in Swiss 3T3 cellsRobert M Burk, David F Woodward, Achim H P Krauss, et al.
Molecular Pharmacology|November 28, 2000
Synthetic modification of prostaglandin f(2alpha) indicates different structural determinants for binding to the prostaglandin F receptor versus the prostaglandin transporterV L Schuster, S Itoh, S W Andrews, et al.
Annals of Hematology|February 1, 1997
Acquired factor VIII inhibitors in nonhemophilic patientsD Söhngen, C Specker, D Bach, et al.
Leukemia & Lymphoma|June 27, 1998
Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significanceG Meckenstock, C Aul, B Hildebrandt, et al.
Radiology|January 1, 1988
Femoral head avascular necrosis: MR imaging with clinical-pathologic and radionuclide correlationJ Beltran, L J Herman, J M Burk, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Plos One|January 31, 2015
Delayed contrast enhancement imaging of a murine model for ischemia reperfusion with carbon nanotube micro-CTLaurel M Burk, Ko-Han Wang, John Matthew Wait, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 27, 2016
Eosinophilic esophagitis during peanut oral immunotherapy with omalizumabCaitlin M Burk, Evan S Dellon, Pamela H Steele, et al.
The American Journal of Gastroenterology|January 13, 2016
Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic PhenotypeThomas M Runge, Swathi Eluri, Cary C Cotton, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2015
Modified peanut oral immunotherapy protocol safely and effectively induces desensitizationJ Andrew Bird, Matthew Feldman, Amy Arneson, et al.
Annals of Hematology|June 1, 1994
Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemiaA Heyll, C Aul, F Gogolin, et al.
Advances in Experimental Medicine and Biology|April 1, 2003
Ocular hypotensive activity of prostaglandin F2 alpha (PGF2 alpha) analogs with neutral substituents at position 1 is predicted by the isolated cat iris sphincter smooth muscle preparation but not Ca+ signalling in Swiss 3T3 cellsRobert M Burk, David F Woodward, Achim H P Krauss, et al.
Molecular Pharmacology|November 28, 2000
Synthetic modification of prostaglandin f(2alpha) indicates different structural determinants for binding to the prostaglandin F receptor versus the prostaglandin transporterV L Schuster, S Itoh, S W Andrews, et al.
Annals of Hematology|February 1, 1997
Acquired factor VIII inhibitors in nonhemophilic patientsD Söhngen, C Specker, D Bach, et al.
Leukemia & Lymphoma|June 27, 1998
Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significanceG Meckenstock, C Aul, B Hildebrandt, et al.
Radiology|January 1, 1988
Femoral head avascular necrosis: MR imaging with clinical-pathologic and radionuclide correlationJ Beltran, L J Herman, J M Burk, et al.
Pageof 9